(advanced)
| 09:30 > 10:45 |  |
ORAL SESSION 09 Metabolism and cancer Chairs: Pietro Formisano (Naples, IT) & Derek Le Roith (New York, NY USA) |
|
| 09:30 > 10:00 | Lecture 16 - Reuben J. Shaw (La Jolla, CA USA) AMPK signaling in glucose metabolism and growth control |
||
| 10:00 > 10:30 | Lecture 17 - Michael Pollak (Montreal, CA) Insulin signalling and metformin in relation to cancer: new developments With Unrestricted Educational Grant of Sanofi Aventis |
||
| 10:30 > 10:45 | Oral Presentation 15 (C8-15) - Jutta Nagel Glargine and NPH insulin similary increase colonic cell proliferation and ACF formation |
||
| 10:45 > 11:15 |  |
Coffee break | |
| 11:15 > 12:30 | |
ORAL SESSION 10 Insulin-action and cancer Session not included in the CME program Chairs: Ira Pastan (Bethesda, MD USA) & Riccardo Vigneri (Catania, IT) |
|
| 11:15 > 11:45 | Lecture 18 - Morris F. White (Boston, MA USA) The dark side of IRS-2: cancer and neurodegeneration |
||
| 11:45 > 12:15 | Lecture 19 - Norbert Tennagels (Frankfurt, DE) Metabolic and mitogenic signalling of exogenus insulin(s) |
||
| 12:15 > 12:30 | Oral Presentation 16 (C9-16) - Michael Greene Breast cancer growth and activation of insulin/IGF-1 signaling by circadian disruption |
||
| 12:30 > 14:30 |  |
POSTER SESSION 03 & Buffet Lunch | |
| 14:30 > 16:30 | |
ORAL SESSION 11 Future strategies for treating diabetes Chairs: Stefano Del Prato (Pisa, IT) & Giorgio Sesti (Catanzaro, IT) |
|
| 14:30 > 15:00 | Lecture 20 - Fatima Bosch (barcelona, ES) Gene therapy in diabetes |
||
| 15:00 > 15:30 | Lecture 21 - Markus Stoffel (Zürich, CH) MicroRNAs: regulators of metabolism and therapeutic targets |
||
| 15:30 > 15:45 | Oral Presentation 17 (C10-17) - Lucie Popineau GRB14 inhibition in mouse liver improves glucose tolerance and hepatic steatosis |
||
| 15:45 > 16:00 | Oral Presentation 18 (C10-18) - Olivier Bezy PKCdelta is a regulator of hepatic insulin sensitivity and modifies hepatosteatosis risk |
||
| 16:00 > 16:15 | Oral Presentation 19 (C10-19) - Shiri Karni Ahkenazi NFKB paradox: suppression of glut4 expression with concomitant tranlocation enhancement |
||
| 16:15 > 16:30 | Oral Presentation 20 (C10-20) - Mashito Sakai Cited2 regulates hepatic gluconeogenesis by controlling PGC-1alpha activity |
||
| 16:30 > 17:00 | |
Coffee break | |
| 17:00 > 18:30 | |
ORAL SESSION 12 Diabetes Complications Chairs: Michele Muggeo (Verona, IT) & Yehiel Zick (Rehovot, IL) |
|
| 17:00 > 17:15 | Oral Presentation 21 (C11-21) - E. Dale Abel Insulin signaling is a physiological regulator of myocardial autophagy in vivo |
||
| 17:15 > 17:30 | Oral Presentation 22 (C11-22) - Rossella Menghini Increased expression of TIMP3 protects against diabetes and atherosclerosis |
||
| 17:30 > 17:45 | Oral Presentation 23 (C11-23) - Janice Zabolotny Protein tyrosine phosphatase 1b (PTP1B) regulates wound healing |
||
| 17:45 > 18:00 | Oral Presentation 24 (C11-24) - Eugenia Carvalho Immunosuppressive agents alter glucose metabolism, blood pressure and heart rate in rats |
||
| 18:00 > 18:30 | Lecture 22 - Hans Ulrich Haering (Tübingen, DE) President lecture - Insulin action in human brain |
||
| 18:30 > 19:00 | CONCLUSION CEREMONY | ||
| 18:30 > 18:45 | Francesco Bèguinot (Naples, IT) Conclusion remarks |
||
| 18:45 > 19:00 | XII meeting announcement | ||
| 19:00 > | Farewell Cocktail | ||
